Medicare Enrolled
Dr. Vijay Narendran, M.D., MBA
Hematology & Oncology · Palm Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Narendran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Narendran? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Narendran
Dr. Vijay Narendran is a hematology & oncology in Palm Springs, FL, with 15 years in practice. Based on federal Medicare data, Dr. Narendran performed 86,696 Medicare services across 3,600 unique beneficiaries.
Between the years covered by Open Payments, Dr. Narendran received a total of $5,728 from 50 pharmaceutical and/or device companies across 264 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Narendran is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice▲ Top 9% volume in FL$ $5,728 industry payments
Medicare Practice Summary
Medicare Utilization ↗86,696
Medicare services
Top 9% in FL for hematology & oncology
3,600
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,780 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 23,600 | $43 | $157 |
| Nivolumab injection (Opdivo) | 19,640 | $24 | $88 |
| Iron infusion (Feraheme) | 11,220 | $0 | $3 |
| Oxaliplatin chemotherapy injection | 7,600 | $0 | $0 |
| Anti-nausea injection (fosaprepitant) | 6,600 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 3,240 | $17 | $61 |
| Dexamethasone injection (steroid) | 2,394 | $0 | $0 |
| Epoetin alfa injection (Procrit) for anemia | 1,720 | $6 | $25 |
| Complete blood count (CBC) with differential | 1,217 | $8 | $23 |
| Office visit, established patient (30-39 min) | 1,145 | $101 | $400 |
| Office visit, established patient (20-29 min) | 999 | $72 | $285 |
| Anti-nausea injection (Aloxi/palonosetron) | 960 | $1 | $3 |
| Blood draw (venipuncture) | 816 | $8 | $11 |
| Anti-nausea injection (ondansetron/Zofran) | 764 | $0 | $0 |
| Administration of chemotherapy into vein, 1 hour or less | 523 | $107 | $428 |
| Injection, leucovorin calcium, per 50 mg | 514 | $3 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 482 | $24 | $94 |
| Injection, fluorouracil, 500 mg | 443 | $2 | $6 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 325 | $3 | $12 |
| Hospital follow-up visit, high complexity | 310 | $99 | $320 |
| Injection of additional new drug or substance into vein | 291 | $13 | $50 |
| Drug injection, under skin or into muscle | 182 | $11 | $44 |
| Injection, diphenhydramine hcl, up to 50 mg | 150 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 131 | $23 | $91 |
| Administration of additional new drug or substance into vein, 1 hour or less | 127 | $53 | $208 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 125 | $53 | $213 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 124 | $132 | $602 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 117 | $60 | $238 |
| Infusion, normal saline solution , 1000 cc | 90 | $2 | $8 |
| New patient office visit (45-59 min) | 83 | $128 | $529 |
| Telephone medical discussion with physician, 11-20 minutes | 78 | $65 | $283 |
| Office visit, established patient (10-19 min) | 73 | $44 | $179 |
| Initial hospital admission, high complexity | 70 | $141 | $621 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 62 | $17 | $65 |
| Irrigation of implanted venous access drug delivery device | 61 | $21 | $84 |
| Infusion into a vein for hydration, 31-60 minutes | 58 | $25 | $107 |
| Infusion into a vein for hydration, each additional hour | 53 | $10 | $40 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 53 | $143 | $528 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 47 | $28 | $104 |
| Collection of blood sample from implanted device | 44 | $22 | $83 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 37 | $16 | $63 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 37 | $1 | $5 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 35 | $4 | $18 |
| Office visit, established patient, complex (40-54 min) | 23 | $148 | $568 |
| New patient office visit, complex (60-74 min) | 22 | $184 | $702 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 11 | $144 | $553 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.0% high complexity
80.0% medium
6.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,728
Total received (2018-2024)
Avg $818/year across 7 years
Top 45% in FL for hematology & oncology
50
Companies
264
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,633 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$95 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$362
2023$692
2022$602
2021$228
2020$613
2019$2,508
2018$723
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$656
Janssen Biotech, Inc.
$542
PFIZER INC.
$449
Genentech USA, Inc.
$352
E.R. Squibb & Sons, L.L.C.
$320
Celgene Corporation
$313
Seattle Genetics, Inc.
$260
Amgen Inc.
$226
Bayer HealthCare Pharmaceuticals Inc.
$225
Merck Sharp & Dohme Corporation
$224
Novartis Pharmaceuticals Corporation
$171
AstraZeneca Pharmaceuticals LP
$156
Lilly USA, LLC
$138
Astellas Pharma US Inc
$127
Seagen Inc.
$125
GENZYME CORPORATION
$125
GlaxoSmithKline, LLC.
$125
Incyte Corporation
$100
Intuitive Surgical, Inc.
$89
Eisai Inc.
$71
TerSera Therapeutics LLC
$63
Dova Pharmaceuticals
$58
Foundation Medicine, Inc.
$49
Exelixis Inc.
$49
Pharmacyclics LLC, An AbbVie Company
$48
AbbVie, Inc.
$47
Sobi, Inc
$46
BeiGene USA, Inc.
$41
Merck Sharp & Dohme LLC
$40
Daiichi Sankyo Inc.
$37
AMAG Pharmaceuticals, Inc.
$35
Advanced Accelerator Applications
$33
TOLMAR Pharmaceuticals, Inc.
$29
EISAI INC.
$29
Janssen Pharmaceuticals, Inc
$29
SOBI, INC
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Deciphera Pharmaceuticals Inc.
$26
AbbVie Inc.
$23
Ferring Pharmaceuticals Inc.
$22
Clovis Oncology, Inc.
$21
Aurobindo Pharma USA, Inc.
$21
JAZZ PHARMACEUTICALS INC.
$20
ABBVIE INC.
$20
NOVARTIS PHARMACEUTICALS CORPORATION
$19
Puma Biotechnology, Inc.
$18
ARRAY BIOPHARMA INC
$18
EMD Serono, Inc.
$15
Kyowa Kirin, Inc.
$14
Alexion Pharmaceuticals, Inc.
$12
Top 3 companies account for 28.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · Abraxane · Alecensa · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIGARD · ELITEK · EMPLICITI · ERBITUX · ERLEADA · Enhertu · Erleada · FERAHEME · FIRMAGON · FOUNDATIONONE · GAZYVA · GILOTRIF · Halaven · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INTELLIS ADAPTIVESTIM · Imbruvica · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · KYPHON Balloon Kyphoplasty · Kyprolis · LIBTAYO · LUMOXITI · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lupron · Lutathera · MEKINIST · MVASI · MYLOTARG · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OSTEOCOOL RF ABLATION SYSTEM · PADCEV · PIQRAY · POLIVY · POTELIGEO · PROMACTA · Prolia · QINLOCK · RECOTHROM · Revlimid · Rubraca · SARCLISA · SUTENT · SYNCHROMEDII · Stivarga · TAGRISSO · TECENTRIQ · TECVAYLI · Ultomiris · VENCLEXTA · VOTRIENT · VYXEOS · Venclexta · XALKORI · XARELTO · XOSPATA · XTANDI · Xofigo · Xospata · ZOLADEX · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
38
Per 100K population
2.5
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Narendran is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), and low-engagement industry engagement, with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Narendran experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Narendran performed 23,600 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Narendran receive payments from pharmaceutical companies?
Yes. Dr. Narendran received a total of $5,728 from 50 companies across 264 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Narendran's costs compare to other hematology & oncologys in Palm Springs?
Dr. Narendran's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Narendran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Palm Springs
Browse hematology & oncologys in Palm Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology